| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 3.21M | — |
| Operating expense | — | — |
| Net income | -55.55M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NAMS returned +11.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -20.6% |
| 1 year | +11.5% |
| 5 years | +188.5% |
| All-time high | $41.30 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NAMS would be worth today ›No. NewAmsterdam Pharma Company N.V. has not paid a dividend in the past 12 months.
NewAmsterdam Pharma Company N.V. stock trades on NASDAQ under the ticker symbol NAMS.
NewAmsterdam Pharma Company N.V. is part of the Healthcare sector.
NewAmsterdam Pharma Company N.V. has a market cap of 3.26B USD, based on the latest quote.
NewAmsterdam Pharma Company N.V. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
